Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Operating Income Performance
Above historical average, slight contraction.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-76.32M
↑ 41% above average
Average (9y)
$-128.97M
Historical baseline
Range
High:$-57.81M
Low:$-491.60M
CAGR
-3.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-76.32M | +2.3% |
| 2023 | $-78.10M | -19.3% |
| 2022 | $-65.46M | +11.0% |
| 2021 | $-73.52M | -27.2% |
| 2020 | $-57.81M | +59.8% |
| 2019 | $-143.90M | -60.2% |
| 2018 | $-89.80M | +19.0% |
| 2017 | $-110.90M | +77.4% |
| 2016 | $-491.60M | -380.4% |
| 2015 | $-102.32M | - |